Drug Resistant Models
Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance:
- 10+ cancer types
- 25+ key targets
- 30+ leading drugs
- 100+ resistant models
- Extensive validation data
Our capabilities include cutting-edge bioinformatics and analytical techniques to enable a clear and in-depth understanding of resistance mechanisms
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models
Drug Resistant Models
